OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling
Yuanyuan Zhai, Wenling Zhou, Xu Yan, et al.
Phytomedicine (2022) Vol. 107, pp. 154444-154444
Closed Access | Times Cited: 25

Showing 25 citing articles:

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
Linsen Shi, Lihua Jin, Wendong Huang
Cells (2023) Vol. 12, Iss. 14, pp. 1888-1888
Open Access | Times Cited: 39

Assessing causal relationships between gut microbiota and psoriasis: evidence from two sample Mendelian randomization analysis
Yuan Li, Gaihe Chen, Xiaohuan Hu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Ameliorative Effect of Glycyrrhizic Acid on Diosbulbin B-Induced Liver Injury and Its Mechanism
Xin Wang, Lubing Shi, Yu-Han Zhang, et al.
The American Journal of Chinese Medicine (2025), pp. 1-27
Closed Access

Multiomics combined analysis reveals protective effect of 7-O-α-L-rhamnopyranosyl-kaempferol-3-O-β-D-glucopyranoside on autoimmune hepatitis
Wei Xiao, Zhiqiang Li, Yilei Wang, et al.
Phytomedicine (2025) Vol. 139, pp. 156460-156460
Closed Access

Sanye Tablet regulates gut microbiota and bile acid metabolism to attenuate hepatic steatosis
Yulin Qi, Siqi Du, Wenwen Li, et al.
Journal of Ethnopharmacology (2025), pp. 119514-119514
Closed Access

Metabolic insights into gut microbiota in the pharmacology of natural medicines
Zixin Chen, Junchi Zhou, Xiao Zheng, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 2, pp. 158-168
Closed Access

Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier
Linzhang Zhang, Xiaoyu Jiang, Jiewen Shi, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118649-118649
Closed Access | Times Cited: 3

Saikosaponin a ameliorates diet-induced fatty liver via regulating intestinal microbiota and bile acid profile in laying hens
Jia Feng, Hui Ma, Yanrui Yue, et al.
Poultry Science (2023) Vol. 102, Iss. 12, pp. 103155-103155
Open Access | Times Cited: 8

Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 11

Exploring global research status and trends in anti-obesity effects of traditional Chinese medicine through intestinal microbiota: a bibliometric study
Wenjing Huang, Jiuyuan Wang, Min Kuang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 6

The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications
Zichen Luo, Wei Zhou, Tong Xie, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3385-3415
Open Access | Times Cited: 1

Astragaloside IV Ameliorates Colonic Adenomatous Polyps Development by Orchestrating Gut Bifidobacterium and Serum Metabolome
Luping Wen, Shaowei Gao, Huaxian Chen, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 05, pp. 1527-1554
Closed Access | Times Cited: 1

The Impact of a Natural Ingredients based Intervention Targeting the Nine Hallmarks of Aging on DNA methylation
Natàlia Carreras-Gallo, Rita Dargham, Shealee Thorpe, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Lipidomics reveals the lipid-lowering and hepatoprotective effects of Celosia Semen on high-fat diet-induced NAFLD mice
Jin‐Quan Zhao, Zhou Qiqi, Ke Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118922-118922
Closed Access | Times Cited: 1

Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Sevag Hamamah, Oana C. Iatcu, Mihai Covașă
Nutrients (2024) Vol. 17, Iss. 1, pp. 143-143
Open Access | Times Cited: 1

Simiao Wan attenuates high-fat diet-induced hyperlipidemia in mice by modulating the gut microbiota–bile acid axis
Kexin Wang, Wenjie Xu, Wen He, et al.
Journal of Ethnopharmacology (2024) Vol. 337, pp. 118868-118868
Closed Access

Astragaloside IV alleviates diabetic nephropathy by modulating the kidney-gut axis AMPK/PI3K/AKT pathway
Pin Gong, Hui Long, Qian Yang, et al.
Food Bioscience (2024) Vol. 62, pp. 105448-105448
Closed Access

Regulation of bile acids and their receptor FXR in metabolic diseases
Yao Li, Lulu Wang, Yi Qing, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access

Page 1

Scroll to top